Glioblastoma-secreted soluble CD44 activates tau pathology in the brainSungsu Lim(Convergence Research Center for Diagnosis Treatment and Care System of Dementia), Yun Kyung Kim(Korea Institute of Science and Technology)Experimental & Molecular MedicineApril 1, 201810.1038/s12276-017-0008-7Cited by 43SaveCiteExport RISWatch citationsRelated PapersDevelopment of an Aryloxazole Derivative as a Brain-Permeable Anti-Glioblastoma Agent|Pharmaceutics|2019|3Comprehensive analysis of THz metasurface imaging for glioblastoma in orthotopic xenograft mouse model|Research Square|2022|0